文献速递胰腺与胆道疾病消化内镜

经口胆管镜抗生素预防的系统综述与荟萃分析

Antibiotic prophylaxis for peroral cholangioscopy: a systematic review and meta-analysis.
PubMed 文献 · Gastrointest Endosc · 2026-08-20

该系统综述与荟萃分析检索多个数据库至2026年2月,纳入6项研究共2531例患者和2575例操作,评估经口胆管镜术前抗生素预防是否降低术后胆管炎风险。结果显示预防组胆管炎合并发生率为3.0%,未预防组为7.8%,抗生素预防与较低胆管炎风险相关(RR 0.46,95%CI 0.22-0.95),但证据确定性极低且结果对单项研究剔除敏感。

要点

  • 经口胆管镜术前抗生素预防与术后胆管炎风险降低相关,但仅为边缘显著性。
  • 预防组胆管炎合并发生率3.0%,未预防组7.8%。
  • 证据确定性极低,结果对单项研究剔除敏感,需前瞻性研究验证。

核心结论

  • 抗生素预防与经口胆管镜术后胆管炎风险降低相关,但估计值仅为边缘显著性且对单项研究剔除不稳健。

研究设计与样本

  • 系统综述与荟萃分析,检索Embase、PubMed、Web of Science和Scopus至2026年2月。
  • 纳入6项报告按预防暴露分层的胆管炎研究,共2531例患者和2575例操作。
  • 采用随机效应荟萃分析合并风险比(RR)。

主要发现

  • 预防组胆管炎合并发生率为3.0%,未预防组为7.8%。
  • 抗生素预防与较低胆管炎风险相关(RR 0.46;95%CI 0.22-0.95;I2=40.4%)。
  • 估计值仅为边缘显著性,且对单项研究剔除不稳健。
  • 证据确定性极低。

关键数值与推荐

  • 预防组胆管炎合并发生率3.0%,未预防组7.8%。
  • 抗生素预防与胆管炎风险的RR为0.46(95%CI 0.22-0.95)。
  • 异质性I2=40.4%。

临床怎么用

  • 经口胆管镜术前可考虑抗生素预防以降低术后胆管炎风险,但需结合患者个体情况并知晓证据确定性极低。
  • 最佳患者选择和预防方案尚需前瞻性研究确定。

局限性

  • 证据确定性极低。
  • 结果对单项研究剔除敏感,不稳健。
  • 需前瞻性研究确定最佳患者选择和预防方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Antibiotic prophylaxis (AP) is commonly administered before ERCP with peroral cholangioscopy, but supporting evidence is limited. We evaluated whether prophylaxis reduces postprocedural cholangitis after cholangioscopy. METHODS: We searched Embase, PubMed, Web of Science, and Scopus through February 2026 for studies reporting cholangitis stratified by prophylaxis exposure. Random-effects meta-analysis was used to pool risk ratios (RRs). RESULTS: Six studies including 2531 patients and 2575 procedures were included. The pooled cholangitis rate was 3.0% with prophylaxis and 7.8% without prophylaxis. AP was associated with lower cholangitis risk (RR, 0.46; 95% CI, 0.22-0.95; I2 = 40.4%), although the estimate was of borderline significance and not robust to individual study removal. Certainty of evidence was very low. CONCLUSIONS: AP was associated with a reduction in postcholangioscopy cholangitis that was of borderline significance and sensitive to individual studies. Prospective studies are needed to define optimal patient selection and regimens.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Alsaleh T, Fawwaz B, Almujarkesh MK, et al. Antibiotic prophylaxis for peroral cholangioscopy: a systematic review and meta-analysis. Gastrointest Endosc. 2026. PMID: 42624299. doi:10.1016/j.gie.2026.08.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。